文献速递细菌感染、耐药与抗菌药物

门诊行为性抗菌药物管理干预:针对医生的系统评价与Meta分析

Behavioural antimicrobial stewardship interventions in outpatient settings: a systematic review and meta-analysis of physician-targeted approaches.
PubMed 文献 · Clin Microbiol Infect · 2026-09-12

RCT中干预降低总体抗生素使用(0.89;95%CI 0.84-0.94)和不推荐/不当使用(0.61;95%CI 0.49-0.75),提高推荐/一线使用(1.35;95%CI 1.16-1.58);干预组分越多效果越好。

要点

  • 行为性AMS干预可减少门诊不推荐/不当抗生素处方(RCT:0.61;95%CI 0.49-0.75)。
  • 干预可提高推荐/一线抗生素使用(RCT:1.35;95%CI 1.16-1.58)。
  • 每增加一个干预组分,不推荐/不当使用进一步降低(RCT 13%;95%CI 0.76-0.99)。

核心结论

  • 针对门诊医生的行为性AMS干预减少不推荐/不当抗生素处方并提高推荐/一线使用,对总体使用量影响较温和,且干预组分越多效果越强。

主要发现

  • RCT中行为性AMS干预降低总体抗生素使用(0.89;95%CI 0.84-0.94)和不推荐/不当使用(0.61;95%CI 0.49-0.75),提高推荐/一线使用(1.35;95%CI 1.16-1.58)。
  • 非RCT中对应估计分别为总体使用0.88(95%CI 0.77-1.01)、不推荐/不当使用0.54(95%CI 0.47-0.62)、推荐/一线使用1.52(95%CI 1.34-1.71)。
  • Meta回归显示每增加一个干预组分,不推荐/不当使用降低幅度更大(RCT 13%;95%CI 0.76-0.99),总体使用降低幅度在非RCT中为7%(95%CI 0.86-0.99)。
  • RCT中激励与问责、沟通及患者参与也显示总体和不适当使用的显著降低,但基于较少研究。

关键数值与推荐

  • 纳入随机对照试验(RCT)和非RCT,评估至少包含一个行为组分的AMS干预,参与者为基层医生。
  • 干预按两个维度分为七大类,并按组分数(单一、组合、多组分)分类。
  • 使用修订版Cochrane偏倚风险工具和Joanna Briggs Institute工具评估偏倚风险。
  • 采用随机效应Meta分析计算调整和粗估计值,并按研究设计分层。

临床怎么用

  • 门诊可优先采用多组分行为性AMS干预以更有效减少不推荐/不当抗生素处方。
  • 干预设计可纳入激励与问责、沟通技巧及患者参与等行为组分。

局限性

  • 非RCT中总体抗生素使用的估计置信区间包含无效值(0.88;95%CI 0.77-1.01)。
  • 激励与问责、沟通及患者参与的显著效果基于较少研究。
  • 纳入研究存在偏倚风险,且异质性可能影响合并估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial stewardship (AMS) interventions are increasingly implemented in outpatient settings to improve the rational use of antibiotics and mitigate antimicrobial resistance. OBJECTIVES: To assess the effect of physician-targeted behavioural AMS interventions on outpatient antibiotic use. METHODS: Data SourcesPubMed/MEDLINE, Cochrane Library, APA PsycNET, and Epistemonikos (PROSPERO CRD420251110732). STUDY ELIGIBILITY CRITERIA: Randomized controlled trials (RCTs) and non-RCTs evaluating AMS interventions. PARTICIPANTS: Primary care physicians. INTERVENTIONS: AMS interventions with at least one behavioural component. Assessments of risk of bias: The revised Cochrane risk-of-bias tool and the Joanna Briggs Institute tool were used. Methods of data synthesis: We categorized AMS interventions along two dimensions into seven broad types and by number of components (single, combined, and multicomponent). Adjusted and crude estimates were calculated in random-effects meta-analyses to assess overall, recommended/first-line, and nonrecommended/inappropriate antibiotic use, stratified by study design. Univariable random-effects meta-regression was conducted to explore whether intervention effects varied by AMS components. Publication bias was assessed using Egger's test, funnel plots, and sensitivity analysis. RESULTS: Eighty-five studies were included, 43 (50.6%) RCTs and 42 (49.4%) non-RCTs. Among RCTs, behavioural AMS interventions reduced overall antibiotic use (0.89; 95% CI, 0.84-0.94) and nonrecommended/inappropriate use (0.61; 95% CI, 0.49-0.75) and increased recommended/first-line use (1.35; 95% CI, 1.16-1.58). Corresponding estimates for non-RCTs were as follows: 0.88 (95% CI, 0.77-1.01), 0.54 (95% CI, 0.47-0.62), and 1.52 (95% CI, 1.34-1.71). In meta-regression, each additional intervention component was consistently associated with a greater reduction in nonrecommended/inappropriate use (RCTs 13%; 95% CI, 0.76-0.99) and overall use (non-RCTs 7%; 95% CI, 0.86-0.99). Incentives and accountability, communication, and patient engagement also showed statistically significant reductions in overall and inappropriate use among RCTs but were based on fewer studies. CONCLUSIONS: Outpatient physician-targeted behavioural AMS interventions reduce inappropriate antibiotic prescribing and increase recommended/first-line use, with more modest effects on overall volume; intervention effectiveness increased with the number of components.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Zhazykhbayeva D, Kosherova Z, Salpynov Z, et al. Behavioural antimicrobial stewardship interventions in outpatient settings: a systematic review and meta-analysis of physician-targeted approaches. Clin Microbiol Infect. 2026. PMID: 42731627. doi:10.1016/j.cmi.2026.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。